v3.25.2
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Jun. 30, 2025
Dec. 31, 2024
Current assets    
Cash and cash equivalents $ 487,933 $ 455,731
Marketable securities 394,878 364,645
Accounts receivable, net 69,761 63,009
Prepaid expenses and other current assets 44,270 41,033
Inventory, net 5,456 5,446
Total current assets 1,002,298 929,864
Property and equipment, net 9,548 10,092
Operating lease right of use assets, net 39,428 37,643
Deferred tax assets, net 14,077 14,790
Other non-current assets 17,036 17,117
Total assets 1,082,387 1,009,506
Current liabilities    
Accounts payable 23,856 25,100
Accrued expenses and other current liabilities 143,785 185,534
Deferred revenue, current 594 0
Operating lease liabilities, current 1,843 1,547
Total current liabilities 170,078 212,181
Accrued expenses, non-current 83,960 0
Deferred revenue, non-current 5,247 5,434
Operating lease liabilities, non-current 42,561 40,162
Interest-bearing loans and borrowings 392,060 391,013
Total liabilities 693,906 648,790
Commitments and contingencies (Note 10)
Shareholders’ equity    
Ordinary shares (voting and non-voting), £0.002 par value, most recent authority to allot up to a maximum nominal value of £149,633 and £97,454 shares as of June 30, 2025 and December 31, 2024, respectively, and 50,372,068 and 50,064,860 shares issued and outstanding as of June 30, 2025 and December 31, 2024, respectively. 135 135
Deferred shares, £0.0001 par value, 5,793,501 shares authorized, issued and outstanding as of June 30, 2025 and December 31, 2024. 1 1
Additional paid-in capital 1,215,997 1,190,104
Accumulated deficit (801,038) (795,761)
Accumulated other comprehensive loss (26,614) (33,763)
Total shareholders' equity 388,481 360,716
Total liabilities and shareholders' equity $ 1,082,387 $ 1,009,506